ASLAN Pharmaceuticals Ltd (ASLN)
0.4351
+0.04
(+8.78%)
USD |
NASDAQ |
May 16, 16:00
0.444
+0.01
(+2.05%)
After-Hours: 20:00
ASLAN Pharmaceuticals Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2018 | -23.09M |
September 30, 2018 | -23.10M |
June 30, 2018 | -22.31M |
March 31, 2018 | -12.36M |
December 31, 2017 | -0.3364M |
Date | Value |
---|---|
September 30, 2017 | -0.4658M |
June 30, 2017 | -0.609M |
March 31, 2017 | -0.55M |
December 31, 2016 | -0.5235M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
Dr Reddy's Laboratories Ltd | -486.60M |
Concord Medical Services Holdings Ltd | -- |
WAVE Life Sciences Ltd | -1.043M |
Zai Lab Ltd | 46.47M |
CytoMed Therapeutics Ltd | -2.096M |